Most peptide research focuses on one compound at a time. Glow-70 takes a different approach — combining three well-researched peptides into a single bundle, each targeting a different biological pathway involved in skin health and tissue biology.
The three compounds are GHK-Cu, TB-500, and BPC-157. They don’t overlap. They don’t compete. They work on different systems entirely — which is exactly why researchers study them together. This article breaks down what each one does, why the combination makes scientific sense, and what the research looks like across all three.
Research Use Educational Framework
- Educational reference content only
- Structural stability awareness
- Environmental handling considerations
- Analytical quality and purity awareness
- Non-clinical research context
GHK-Cu: Four Decades of Skin Biology Research
GHK-Cu (copper peptide GHK) is one of the most studied compounds in cosmeceutical peptide research. It was first identified in human plasma in the 1970s, and the decades of research that followed have built one of the most comprehensive datasets of any skin-focused peptide.
The core of GHK-Cu’s research profile is its role in collagen and elastin synthesis. Studies have shown it stimulates fibroblast activity — the cells responsible for producing the structural proteins that give skin its firmness and elasticity. But the research goes further than that. GHK-Cu has been studied for its effects on glycosaminoglycan production, wound healing signaling, and gene expression — with some research suggesting it influences hundreds of genes involved in tissue maintenance and repair.
The copper component isn’t just structural. Copper is an essential cofactor for lysyl oxidase — an enzyme critical for cross-linking collagen and elastin fibers into a stable matrix. Without adequate copper, even well-synthesized collagen doesn’t assemble properly. GHK-Cu delivers copper in a form that research suggests is highly bioavailable to skin tissue. For a broader look at skin-focused peptide research, our Peptides for Skin Care Research guide covers the landscape.
TB-500: Cytoskeletal Dynamics and Tissue Remodeling
TB-500 is a synthetic analog of Thymosin Beta-4 — a naturally occurring peptide found in virtually every cell in the human body. Its research profile is built around a process called cytoskeletal dynamics: specifically, how cells regulate actin, the protein that gives cells their structure and enables them to move.
Here’s why that matters for tissue research. When tissue is damaged or stressed, cells need to reorganize, migrate to the site of injury, and begin repair processes. All of that movement is driven by actin dynamics. TB-500 works by binding to G-actin — the unpolymerized form of actin — which promotes cell mobility and the kind of tissue remodeling that underpins repair processes.
In skin biology research specifically, TB-500 has been studied for its effects on angiogenesis (the formation of new blood vessels), which is a critical component of tissue repair and nutrient delivery. It’s also been investigated for anti-inflammatory properties in tissue models — making it relevant not just to structural repair but to the inflammatory environment that often accompanies skin stress and damage. This is a different biological lane from GHK-Cu entirely, which is the point of studying them together.
BPC-157: Stability, Cytoprotection and Signaling
BPC-157 stands for Body Protection Compound 157 — a 15-amino acid synthetic peptide derived from a protective protein found in gastric juice. Its stability is one of its most distinctive research characteristics: unlike many peptides that degrade rapidly in biological environments, BPC-157 demonstrates remarkable stability in gastric acid conditions, which has made it a subject of interest across a wide range of research contexts.
The research on BPC-157 spans multiple signaling pathways. Studies have examined its effects on VEGFR2 (vascular endothelial growth factor receptor), FAK (focal adhesion kinase), and the JAK-2/STAT-3 pathway — all of which play roles in tissue repair, angiogenesis, and cellular survival signaling. In skin and connective tissue models, it’s been investigated for its cytoprotective properties and its potential to accelerate the early phases of tissue repair.
What makes BPC-157 a logical addition to the Glow-70 bundle is that it addresses a different dimension of the repair process than either GHK-Cu or TB-500. Where GHK-Cu focuses on structural matrix synthesis and TB-500 on cellular mobility and angiogenesis, BPC-157 research has centered on the signaling environment that governs whether repair processes initiate effectively in the first place.
Why Three Compounds Together?
The scientific rationale for studying GHK-Cu, TB-500, and BPC-157 as a bundle comes down to one principle: non-overlapping mechanisms. Each compound works on a different biological system, which means combining them in research doesn’t create redundancy — it creates breadth.
GHK-Cu targets the structural side: collagen synthesis, elastin production, extracellular matrix integrity. TB-500 targets cellular mobility and the actin dynamics that enable tissue remodeling and new blood vessel formation. BPC-157 targets the signaling environment — the upstream pathways that govern whether repair processes get off the ground efficiently. Together they represent three distinct phases of how skin tissue maintains and restores itself at the cellular level.
This is why combination peptide research is a growing area of cosmeceutical science. Single-compound studies are essential for isolating mechanism, but multi-compound models reflect something closer to how biological systems actually operate — with multiple pathways active simultaneously. The Glow-70 bundle was designed with that research logic in mind. For a foundational look at how peptides interact with biological signaling systems, our Peptide Mechanisms and Signaling Pathways guide is a useful reference.
Bundle Composition and Research Context
The Glow-70 name reflects the total peptide content in the bundle: 70mg across the three compounds. The composition is weighted toward GHK-Cu, which is typically studied at higher concentrations given its well-established dose-response profile in collagen synthesis research, with TB-500 and BPC-157 included at concentrations consistent with their research literature.
All three compounds in the bundle have individual research profiles spanning multiple decades and research contexts — which means investigators working with Glow-70 have access to a substantial body of single-compound literature to contextualize their findings against. This is a meaningful advantage in formulation and combination research, where understanding how each compound behaves independently is essential for interpreting results in a multi-compound model.
BioStrata Research supplies each compound individually for researchers who need them separately: GHK-Cu – 100mg, TB-500 – 10mg, and BPC-157 – 10mg. The Glow-70 bundle is available for researchers studying multi-peptide formulation science within our Skin & Cosmetic Research category.
FAQ — Glow-70 Peptide Bundle Research
What is Glow-70? Glow-70 is a multi-peptide research bundle combining three compounds — GHK-Cu, TB-500, and BPC-157 — into a single 70mg formulation. Each compound targets a different biological pathway involved in skin and tissue research, making it a tool for investigators studying multi-mechanism approaches to skin biology.
Why are these three peptides studied together? The three compounds work through non-overlapping mechanisms. GHK-Cu targets collagen and elastin synthesis and extracellular matrix support. TB-500 targets cellular mobility, actin dynamics, and angiogenesis. BPC-157 targets cytoprotective signaling pathways involved in the early phases of tissue repair. Because they don’t compete or duplicate each other’s actions, combining them in research reflects how multiple biological repair systems operate simultaneously.
Can I research these compounds individually? Yes. BioStrata Research supplies all three compounds separately — GHK-Cu – 100mg, TB-500 – 10mg, and BPC-157 – 10mg — for researchers who need single-compound models or want to control dosing independently across each peptide.
How does Glow-70 differ from Snap-8? Snap-8 targets the neuromuscular side of skin biology — specifically the nerve-to-muscle signaling involved in facial muscle contraction. Glow-70’s three compounds target structural synthesis, cellular repair dynamics, and cytoprotective signaling. They address entirely different dimensions of skin biology and are sometimes studied in combination for that reason.
Is Glow-70 available for research use? Yes. BioStrata Research supplies the Glow-70 bundle as a research-grade compound verified at ≥99% purity by HPLC, available for qualified laboratory and formulation research use. All products are designated Research Use Only (RUO) and not intended for human or veterinary use.
- CONTINUE LEARNING
Explore Related Peptide Topics
Continue building your understanding by exploring related foundational peptide topics.